EquityZen Growth Technology Fund LLC - Series 1019
Raised
$559K
Investors
28
Min Invest
$2,095
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1019 is a Delaware pooled investment fund filed by EquityZen Advisors LLC, raising $559K from 28 investors with a $2K minimum investment under Rule 506(b) and Section 3(c)(1). This is an amended filing dated 2021-11-23, part of EquityZen's platform of 1889+ pre-IPO special purpose vehicles enabling secondary market access to private company shares.
This pre-IPO vehicle follows the standard EquityZen series SPV model with a low $2K minimum, designed for retail accredited investor participation in private company secondaries. The 506(b) and 3(c)(1) exemption pairing is typical for sub-100 investor pooled vehicles, and the $20K average check size ($559K / 28 investors) aligns with democratized access strategies common to secondary market platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
